142 related articles for article (PubMed ID: 15980883)
1. Favourable response to antithymocyte globulin therapy in resistant acute graft-versus-host disease.
Tagliabue A; Corti P; Viganò E; Bonanomi S; Uderzo C
Bone Marrow Transplant; 2005 Sep; 36(5):459. PubMed ID: 15980883
[No Abstract] [Full Text] [Related]
2. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.
Wall DA; Carter SL; Kernan NA; Kapoor N; Kamani NR; Brochstein JA; Frangoul H; Goyal RK; Horan JT; Pietryga D; Wagner JE; Kurtzberg J;
Biol Blood Marrow Transplant; 2005 Aug; 11(8):637-46. PubMed ID: 16041314
[TBL] [Abstract][Full Text] [Related]
3. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
4. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.
Kröger N; Zabelina T; Binder T; Ayuk F; Bacher U; Amtsfeld G; Lellek H; Schrum J; Erttmann R; Eiermann T; Zander A
Biol Blood Marrow Transplant; 2009 Apr; 15(4):454-62. PubMed ID: 19285633
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation in childhood acute lymphoblastic leukemia with closely matched family donors in Hong Kong.
Yuen PM; Chik KW; Li CK; Shing MM; Lai H
Transplant Proc; 1996 Jun; 28(3):1748-9. PubMed ID: 8658866
[No Abstract] [Full Text] [Related]
6. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
[TBL] [Abstract][Full Text] [Related]
7. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
Godder KT; Henslee-Downey PJ; Mehta J; Park BS; Chiang KY; Abhyankar S; Lamb LS
Bone Marrow Transplant; 2007 Jun; 39(12):751-7. PubMed ID: 17450185
[TBL] [Abstract][Full Text] [Related]
8. Pseudotumor cerebri after allogeneic bone marrow transplant associated with cyclosporine a use for graft-versus-host disease prophylaxis.
Somech R; Doyle J
J Pediatr Hematol Oncol; 2007 Jan; 29(1):66-8. PubMed ID: 17230071
[TBL] [Abstract][Full Text] [Related]
9. Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL.
Talano JM; Casper JT; Camitta BM; Keever-Taylor CA; Murray KJ; Eapen M; Pierce KL; Margolis DA
Bone Marrow Transplant; 2006 Jan; 37(2):135-41. PubMed ID: 16273115
[TBL] [Abstract][Full Text] [Related]
10. Generalized vitiligo after allogeneic bone marrow transplantation.
Cho SB; Roh MR; Chung KY; Lee KH; Park YK
Acta Derm Venereol; 2005; 85(1):82-3. PubMed ID: 15849005
[No Abstract] [Full Text] [Related]
11. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
Bacigalupo A; Lamparelli T; Barisione G; Bruzzi P; Guidi S; Alessandrino PE; di Bartolomeo P; Oneto R; Bruno B; Sacchi N; van Lint MT; Bosi A;
Biol Blood Marrow Transplant; 2006 May; 12(5):560-5. PubMed ID: 16635791
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
Ayuk F; Perez-Simon JA; Shimoni A; Sureda A; Zabelina T; Schwerdtfeger R; Martino R; Sayer HG; Alegre A; Lahuerta JJ; Atanackovic D; Wolschke C; Nagler A; Zander AR; San Miguel JF; Kröger N
Haematologica; 2008 Sep; 93(9):1343-50. PubMed ID: 18641030
[TBL] [Abstract][Full Text] [Related]
13. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
[TBL] [Abstract][Full Text] [Related]
14. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
15. Extramedullary relapse of therapy-related myelodysplastic syndrome after donor leukocyte infusion.
Chao MM; Kontny U; Brink I; Göhring G; Schmitt-Gräff A; Rister M; Strahm B
Ann Hematol; 2008 Feb; 87(2):165-6. PubMed ID: 17805535
[No Abstract] [Full Text] [Related]
16. Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin.
Sedlácek P; Formánková R; Keslová P; Srámková L; Hubácek P; Król L; Kulich M; Starý J
Bone Marrow Transplant; 2006 Dec; 38(11):745-50. PubMed ID: 17041606
[TBL] [Abstract][Full Text] [Related]
17. Is survival enough for myelodysplastic syndromes?
Santini V
Leuk Res; 2009 Aug; 33(8):1017-8. PubMed ID: 19268362
[No Abstract] [Full Text] [Related]
18. Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia.
Osugi Y; Yagasaki H; Sako M; Kosaka Y; Taga T; Ito T; Yamamoto M; Ohara A; Sato T; Mimaya J; Tsukimoto I; Kojima S;
Haematologica; 2007 Dec; 92(12):1687-90. PubMed ID: 18055993
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic bone marrow transplantation in children - eight years experience of Paediatric BMT Unit in Poznań.
Wachowiak J; Boruczkowski D; Malicki J; Kaczmarek-Kanold M; Chobot-Musiałkiewicz U; Radwańska U
Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S63-6. PubMed ID: 9916639
[No Abstract] [Full Text] [Related]
[Next] [New Search]
